Nuveen LLC acquired a new position in Vita Coco Company, Inc. (NASDAQ:COCO - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 99,211 shares of the company's stock, valued at approximately $3,041,000. Nuveen LLC owned 0.17% of Vita Coco as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also made changes to their positions in COCO. CWM LLC increased its stake in shares of Vita Coco by 14.7% in the first quarter. CWM LLC now owns 2,868 shares of the company's stock worth $88,000 after purchasing an additional 367 shares during the period. US Bancorp DE increased its stake in shares of Vita Coco by 7.5% in the first quarter. US Bancorp DE now owns 5,247 shares of the company's stock worth $161,000 after purchasing an additional 364 shares during the period. PNC Financial Services Group Inc. increased its stake in shares of Vita Coco by 16.5% in the first quarter. PNC Financial Services Group Inc. now owns 5,343 shares of the company's stock worth $164,000 after purchasing an additional 758 shares during the period. Goldstone Financial Group LLC acquired a new stake in Vita Coco during the first quarter worth about $231,000. Finally, Simplicity Wealth LLC acquired a new stake in Vita Coco during the first quarter worth about $319,000. 88.49% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
A number of research firms recently weighed in on COCO. Morgan Stanley lifted their target price on Vita Coco from $35.00 to $38.00 and gave the stock an "equal weight" rating in a research report on Thursday, July 31st. Piper Sandler raised Vita Coco from a "neutral" rating to an "overweight" rating and set a $39.00 target price on the stock in a research report on Wednesday, August 20th. Wall Street Zen downgraded Vita Coco from a "buy" rating to a "hold" rating in a research report on Saturday, June 7th. Finally, Wells Fargo & Company lifted their target price on Vita Coco from $43.00 to $45.00 and gave the stock an "overweight" rating in a research report on Thursday, July 31st. Five equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Vita Coco presently has a consensus rating of "Moderate Buy" and an average price target of $38.38.
View Our Latest Stock Report on Vita Coco
Vita Coco Stock Performance
NASDAQ COCO traded up $0.50 during trading on Monday, reaching $35.74. 527,196 shares of the company traded hands, compared to its average volume of 751,348. The stock's 50 day moving average price is $35.90 and its two-hundred day moving average price is $34.48. The company has a market cap of $2.03 billion, a price-to-earnings ratio of 33.40, a P/E/G ratio of 1.89 and a beta of 0.36. Vita Coco Company, Inc. has a 1-year low of $24.09 and a 1-year high of $40.32.
Vita Coco (NASDAQ:COCO - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The company reported $0.38 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. The company had revenue of $168.76 million for the quarter, compared to the consensus estimate of $162.20 million. Vita Coco had a return on equity of 24.99% and a net margin of 11.50%.The company's quarterly revenue was up 17.1% on a year-over-year basis. During the same period in the previous year, the business earned $0.32 earnings per share. Vita Coco has set its FY 2025 guidance at EPS. Equities research analysts expect that Vita Coco Company, Inc. will post 1.07 EPS for the current fiscal year.
Insider Buying and Selling
In other news, insider Es Charles Van sold 10,000 shares of the business's stock in a transaction that occurred on Monday, July 7th. The stock was sold at an average price of $38.02, for a total value of $380,200.00. Following the transaction, the insider directly owned 94,127 shares of the company's stock, valued at $3,578,708.54. The trade was a 9.60% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Kenneth Sadowsky sold 3,900 shares of the business's stock in a transaction that occurred on Wednesday, July 16th. The stock was sold at an average price of $37.65, for a total value of $146,835.00. Following the completion of the transaction, the director directly owned 631,666 shares in the company, valued at $23,782,224.90. The trade was a 0.61% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 40,952 shares of company stock valued at $1,500,913 over the last ninety days. Company insiders own 34.20% of the company's stock.
Vita Coco Profile
(
Free Report)
The Vita Coco Company, Inc develops, markets, and distributes coconut water products under the Vita Coco brand name in the United States, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company offers coconut oil and coconut milk; juice; Runa, a plant-based energy drink; packaged water under the Ever & Ever brand name; and PWR LIFT, a protein-infused fitness drink.
See Also

Before you consider Vita Coco, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vita Coco wasn't on the list.
While Vita Coco currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.